Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Cash from Investing Activities (2020 - 2022)

Historic Cash from Investing Activities for Ensysce Biosciences (ENSC) over the last 2 years, with Q1 2022 value amounting to $4500.0.

  • Ensysce Biosciences' Cash from Investing Activities changed N/A to $4500.0 in Q1 2022 from the same period last year, while for Dec 2022 it was $4500.0, marking a year-over-year change of. This contributed to the annual value of $4500.0 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q1 2022, Ensysce Biosciences' Cash from Investing Activities is $4500.0.
  • In the past 5 years, Ensysce Biosciences' Cash from Investing Activities ranged from a high of $183.4 million in Q4 2020 and a low of -$182.8 million during Q3 2020